Earnings History Data for Champions Oncology, Inc. (CSBR) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Champions Oncology, Inc.
Champions Oncology, Inc., formerly known as Champions Biotechnology, Inc., engages in the development of advanced technology solutions to personalize the development and use of oncology drugs. The Company's Tumorgraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments. This technology can evaluate tumor sensitivity/resistance to various single, combination standard and novel chemotherapy agents. Champions Oncology, Inc. is based in Baltimore, Maryland.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 18-07-2024 | AH | CSBR | Champions Oncology, Inc. | 68.10 | -0.01 | 0.00 | -0.19 | Champions Oncology Non-GAAP EPS of $0.01, revenue of $14M beats by $1.31M [7/18/2024 4:50 PM] |
4.98 | 0.06 (1.22%) |
5.12 | 0.20 (4.07%) |
4.50 - 7.14 | 21,219 | 0 | 862 | ||
| 12-12-2023 | AH | CSBR | Champions Oncology, Inc. | 66.99 | -0.15 | -0.17 | 0.00 | Champions Oncology Non-GAAP EPS of -$0.15 beats by $0.01, revenue of $11.57M misses by $1.26M [12/12/2023 4:05 PM] |
4.78 | 0.17 (3.69%) |
4.65 | 0.04 (0.87%) |
3.75 - 7.32 | 24,862 | 10,000 | 2,446 | ||
| 24-07-2023 | AH | CSBR | Champions Oncology, Inc. | 93.55 | -0.19 | 0.00 | -0.03 | Champions Oncology Non-GAAP EPS of -$0.17 misses by $0.02, revenue of $13.1M beats by $0.24M [7/24/2023 4:15 PM] |
6.48 | 0.07 (1.09%) |
6.37 | -0.04 (-0.62%) |
3.75 - 9.88 | 8,756 | 10,000 | 661 | ||
| 15-03-2023 | AH | CSBR | Champions Oncology, Inc. | 59.66 | -0.18 | -0.06 | 0.05 | Champions Oncology Non-GAAP EPS of -$0.16 misses by $0.15, revenue of $12.77M misses by $0.36M [3/15/2023 5:05 PM] |
4.01 | -0.09 (-2.20%) |
0.0 | 0.0 (0.00%) |
3.75 - 9.88 | 40,978 | 10,000 | 0 | ||
| 08-09-2022 | AH | CSBR | Champions Oncology, Inc. | 116.97 | -0.02 | 0.01 | -0.01 | Champions Oncology GAAP EPS of -$0.02 misses by $0.03, revenue of $13.7M beats by $0.51M [9/8/2022 4:18 PM] |
7.50 | 0.24 (3.31%) |
0.0 | 0.0 (0.00%) |
6.81 - 10.90 | 8,215 | 0 | 0 | ||
| 21-07-2022 | AH | CSBR | Champions Oncology | 111.00 | -0.03 | 0.02 | 0.00 | Champions Oncology Non-GAAP EPS of -$0.02, revenue of $12.9M [7/21/2022 4:41 PM] |
8.92 | 0.92 (11.50%) |
8.00 | 0.0 (0.00%) |
6.81 - 11.00 | 19,251 | 10,000 | 100 | ||
| 15-03-2022 | AH | CSBR | Champions Oncology | 110.00 | 0.05 | 0.03 | 0.00 | Champions Oncology Non-GAAP EPS of $0.07, revenue of $13.2M [3/15/2022 5:02 PM] |
8.21 | 0.66 (8.74%) |
0.0 | 0.0 (0.00%) |
7.06 - 14.03 | 16,049 | 7,170 | 0 | ||
| 13-12-2021 | AH | After the close (Dec 13) |
CSBR | Champions Oncology, Inc. | 109.52 | 0.02 | 0.00 | 0.00 | Champions Oncology EPS beats by $0.02, beats on revenue [12/13/2021 4:22 PM] |
8.23 | 0.19 (2.41%) |
0.0 | 0.0 (0.00%) |
7.80 - 14.68 | 15,369 | 10,000 | 0 | |
| 13-09-2021 | AH | 4:00 PM ET (Sep 13) |
CSBR | Champions Oncology, Inc. | 139.11 | -0.01 | 0.01 | 0.01 | Champions Oncology EPS in-line, beats on revenue [9/13/2021 4:16 PM] |
10.09 | -0.01 (-0.10%) |
10.21 | 0.11 (1.09%) |
7.39 - 14.68 | 12,294 | 100,000 | 827 | |
| 22-07-2021 | PM | 0:00 AM ET (Jul 22) |
CSBR | Champions Oncology, Inc. | 130.96 | -0.04 | 0.01 | -0.17 | Champions Oncology beats on revenue [7/22/2021 8:48 AM] |
9.92 | -0.17 (-1.68%) |
0.0 | 0.0 (0.00%) |
7.05 - 14.68 | 28,951 | 10,000 | 0 | |
| 11-03-2021 | AH | CSBR | Champions Oncology, Inc. | 147.33 | 0.05 | 0.01 | 0.03 | Champions Oncology EPS beats by $0.04, beats on revenue [3/11/2021 5:47 PM] |
11.58 | 0.58 (5.27%) |
11.90 | 0.90 (8.18%) |
4.02 - 13.45 | 32,889 | 33,585 | 1,134 | ||
| 14-12-2020 | AH | After the close (Dec 14) |
CSBR | Champions Oncology, Inc. | 145.10 | N/A | 0.01 | 0.02 | Champions Oncology beats on revenue [12/14/2020 4:02 PM] |
11.31 | -0.24 (-2.08%) |
11.80 | 0.25 (2.16%) |
4.02 - 13.45 | 113,859 | 33,184 | 110 | |
| 14-09-2020 | AH | 7:05 PM ET (Sep 14) |
CSBR | Champions Oncology, Inc. | 90.00 | 0.01 | 0.02 | 0.00 | Champions Oncology EPS beats by $0.01, beats on revenue [9/14/2020 4:03 PM] |
8.38 | 0.80 (10.49%) |
8.62 | 1.04 (13.72%) |
4.02 - 10.89 | 78,455 | 24,801 | 258 | |
|
|
||||||||||||||||||